Dr. Chen-Ket Chai has extensive experience in the field of quality management and assurance. Currently, they hold the position of Director of Quality Management at Greiner Bio-One International, where they are responsible for ensuring the implementation and maintenance of quality management systems. Dr. Chen-Ket also oversees a team of engineers and quality managers and is involved in various aspects of quality control and assurance. Prior to this, Dr. Chai worked as a Team Leader in Quality Management and Quality Assurance at Fresenius Medical Care, where they supervised a team and was responsible for change management, complaint investigation, and equipment qualification. Dr. Chen-Ket has also worked as a Research Scientist at Eindhoven University of Technology and as an Academic Visitor at the University of Oxford. Overall, Dr. Chai's work experience reflects their expertise in quality management, supervision, and research in the medical field.
Dr. Chen-Ket Chai earned a Doctor of Philosophy (Ph.D.) in Biomedical/Medical Engineering from Eindhoven University of Technology between 2010 and 2015. Prior to that, they completed a Master of Science (M.Sc.) in Biomedical/Medical Engineering from Leibniz Universität Hannover from 2008 to 2010. Their earlier education includes a Diplom-Ingenieur (FH) in Biomedical/Medical Engineering from Hochschule Anhalt, which was completed between 2003 and 2008. Dr. Chen-Ket Chai also holds additional certifications, including Leadership from IHK Hannover obtained in 2021, Certified Professional in Supply Management (CPSM) from TÜV Süd obtained in 2020, and Technical documentation for medical devices from TÜV Süd obtained in 2015.
This person is not in any teams
This person is not in any offices
Greiner Bio-One International
3 followers
Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One has specialised in two business division, Preanalytics and BioScience. The Preanalytics business division, with headquarters in Kremsmünster (Austria), develops and produces innovative collection systems for human and veterinary blood, urine and saliva samples, with the aim of making day-to-day, routine tasks in hospitals, laboratories and doctors’ practices easier and safer. This division also covers customised software solutions (Greiner eHealth Technologies) which ensure greater efficiency and patient safety in the preanalytical process. Greiner Bio-One’s BioScience division, with headquarters in Frickenhausen (Germany), is one of the leading providers of specialist products for the cultivation and analysis of cell and tissue cultures. Based on decades of experience in the cryopreservation of samples, Greiner Bio-One also offers solutions for automated storage systems in biobanks. In addition, the division also develops and produces microplates for high-throughput screening, which ensure the quickest and most efficient testing of substances and materials in both industry and research. Greiner Bio-One (then Greiner Labortechnik) was founded in 1963 in Nürtingen (Germany) and started with the manufacture of the first plastic Petri dishes. Today, Greiner Bio-One International GmbH is located in 28 locations in 22 countries. The company employs 2,540 people and is part of Greiner AG, headquartered in Kremsmünster (Austria).